Yisha She

Title: Yisha She - Innovator in Tumor-targeting Therapeutics

Introduction

Yisha She is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic solutions for cancer treatment. His work focuses on creating bispecific recombinant proteins that enhance the efficacy of tumor-targeting therapies.

Latest Patents

Yisha She holds a patent for a bispecific recombinant protein and its applications. This innovative protein comprises a high affinity tumor-targeting arm and a low affinity fusion protein that blocks the interaction of CD47 with SIRPα. The antibody corresponding to the high affinity tumor-targeting arm does not bind to CD47, ensuring that its binding affinity to the target antigen on the tumor cell is at least six times greater than that of the monomer fusion protein homodimer. This unique design aims to improve the treatment of tumors by utilizing nucleic acid molecules that encode these recombinant proteins.

Career Highlights

Yisha She is associated with Shanghai JMT-Bio Technology Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes. With a focus on innovative solutions, he is dedicated to pushing the boundaries of current medical treatments.

Collaborations

Yisha She collaborates with notable colleagues, including Liping Song and Xiaotian Cui. These partnerships enhance the research environment and foster the development of groundbreaking therapeutic strategies.

Conclusion

Yisha She is a key figure in the field of biotechnology, with a focus on creating effective tumor-targeting therapies. His innovative work and collaborations position him as a leading inventor in the fight against cancer.